Allergan plc AGN
The previous Allergan plc dividend was 74c and it went ex over 1 year ago and it was paid 1 year ago.
There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.88.
|Summary||Previous dividend||Next dividend|
|Declaration date||18 Mar 2020 (Wed)||–|
|Ex-div date||15 Apr 2020 (Wed)||–|
|Pay date||15 Jun 2020 (Mon)||–|
Enter the number of Allergan plc shares you hold and we'll calculate your dividend payments:
Sign up for Allergan plc and we'll email you the dividend information when they declare.
Add Allergan plc to receive free notifications when they declare their dividends.
Your account is set up to receive Allergan plc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Paid||Quarterly||18 Mar 2020||15 Apr 2020||15 Jun 2020||USD||74c||74c||😄|
|Paid||Quarterly||24 Jan 2020||13 Feb 2020||13 Mar 2020||USD||76c||74c||😃|
|Paid||Quarterly||25 Oct 2019||12 Nov 2019||13 Dec 2019||USD||74c||74c||😄|
|Paid||Quarterly||19 Jul 2019||12 Aug 2019||13 Sep 2019||USD||74c||74c||😄|
|Paid||Quarterly||03 May 2019||13 May 2019||14 Jun 2019||USD||74c||74c||😄|
|Paid||Quarterly||25 Jan 2019||14 Feb 2019||15 Mar 2019||USD||—||74c|
|Paid||Quarterly||26 Oct 2018||09 Nov 2018||14 Dec 2018||USD||—||72c|
|Paid||Quarterly||30 Jul 2018||16 Aug 2018||17 Sep 2018||USD||—||72c|
|Paid||Quarterly||03 May 2018||17 May 2018||15 Jun 2018||USD||—||72c|
|Paid||Quarterly||09 Feb 2018||27 Feb 2018||28 Mar 2018||USD||—||72c|
|Paid||Quarterly||27 Oct 2017||16 Nov 2017||15 Dec 2017||USD||—||70c|
|Paid||Quarterly||02 Aug 2017||16 Aug 2017||15 Sep 2017||USD||—||70c|
|Paid||Quarterly||05 May 2017||16 May 2017||15 Jun 2017||USD||—||70c|
|Paid||Quarterly||03 Feb 2017||24 Feb 2017||28 Mar 2017||USD||—||70c|
Allergan plc Optimized Dividend Chart
About Allergan plc
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.
With colleagues and commercial operations located in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients